Article Listing - Chemex And Block Disolve Agreement
BULLETIN REVIEWS NEW TOPICAL PRODUCTS
9 March 1992
Leo Laboratories' Dovonex (calcipotriol) represents an interesting and useful addition to the menu of treatments available for chronic plaque psoriasis,...
UK DTP VACCINATION SCHEDULE
9 March 1992
New findings released by a team of UK clinicians, under the direction of Robert Booy of the Radcliffe Hospital, Oxford,...
MMD'S 5HT3 RECEPTOR ANTAGONIST
9 March 1992
The pharmacokinetic properties of a new anti-emetic 5-HT3 receptor antagonist from Marion Merrell Dow, MDL 73,147EF, will be described at...
FIRST QUARTER LOSS AT ALLELIX
17 February 1992
Canadian biopharmaceutical concern Allelix has reported a loss of around C$300,000 ($254,790) for the first quarter ended November 30, 1991....
RISING HEALTH CARE COSTS IN SPAIN
17 February 1992
Family expenditure in Spain on medication has progressively fallen in recent years, and at the same time, the costs of...
AIDS TREATMENT FROM JOHNSON MATTHEY
17 February 1992
A new potential treatment for AIDS patients has been developed by the precious metals group of UK-based Johnson Matthey. As...
CHINESE DRUG PRODUCTION IN 1991
17 February 1992
Chinese pharmaceutical production was valued at 39.9 billion yuan ($7.4 billion) in 1991, reports the People's Daily, quoted in...
USTR INVITES COMMENTS ON INDIAN PATENT ACTION
17 February 1992
The US Trade Representative, Carla Hills, has intensified her country's pressure on India over the issue of intellectual property rights...
MORTALITY BENEFIT WITH GYNEX' OXANDRIN
17 February 1992
Gynex Pharmaceuticals Inc has reached an agreement with the US Department of Veterans Affairs, giving it access to and use...
MYLAN CLAIMS FDA DISCRIMINATION
17 February 1992
The US Food and Drug Administra-tion is allegedly withholding appr-oval of drugs for Mylan Laborat-ories because the company revealed malpractices...
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
